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Nodalipto-1/FRL-1/Cryptic (EGF-CFC) proteins, including human Cripto-1 (hCFC2/hCR-1)
and human Cryptic (hCFC1), are membrane-associated Nodal co-receptors, which have critical roles in
vertebrate development. Most of the EGF-CFC proteins have been experimentally proven or predicted to be
glycosylphosphatidylinositol (GPI)-anchored proteins. However, unlike other EGF-CFC proteins, hCFC1 does not
exhibit a typical GPI-signal sequence, containing a 32-amino acid hydrophilic extension in its COOH-terminal
end. Here we experimentally demonstrate that the COOH-terminal sequence of hCFC1 functions as a GPI-
anchoring signal. Moreover, addition of a hydrophilic epitope tag of 55-amino acids (V5-His) after the GPI signal
of hCR-1 interfered with generation of a GPI-anchored form of hCR-1. In contrast, addition of the same epitope
tag to the end of GPI signal of hCFC1 did not affect the GPI-attachment of hCFC1. The COOH-terminal signal of
hCFC1 could produce two different forms of the protein; a GPI-anchored form and an unprocessed form which
was more prone to be secreted into the conditioned medium. The hydrophilic extension of hCFC1 negatively
regulates the activity of hCFC1 as a Nodal co-receptor. These results demonstrate the presence of endogenous
GPI-signal sequence with a hydrophilic extension, which can generate both GPI-anchored and soluble forms of
the protein.
Published by Elsevier B.V.1. IntroductionEpidermal Growth Factor-Cripto-1/FRL-1/Cryptic (EGF-CFC) family
of proteins performs an essential role in vertebrate development and
in tumor progression [1,2]. Two functional members of the EGF-CFC
family proteins have been identiﬁed in human; Cripto-1 (hCFC2/hCR-
1) and Cryptic (hCFC1). Knockout studies of mouse orthologous genes
(mCr-1 and mcfc1) suggested that these two genes are essential
during embryonic development [3–5]. Cr-1-null mice are embryonic
lethal at day E8.5-10.5 mainly due to the failure to form appropriate
germ layers [3]. On the other hand, mcfc1-null mice are not embryonic
lethal but die within the ﬁrst 2 weeks because of severe left-right
laterality defects and cardiac malformations [4,5]. Both CR-1 and CFC1
can function as obligatory co-receptors for the TGFβ family ligand
Nodal to facilitate their binding to the Activin type I receptors (ALK) 4/7
and Activin type II receptor [6]. Binding of Nodal to its receptorsto-1; CFC1, Cryptic; EGF-CFC,
; EV, empty vector; GPI,
t Drive Bethesda, MD 20892-
n).
.V.induces Smad2/3 phosphorylation which can heterodimerize with
Smad4 and regulate gene transcription in the presence of the co-
transcriptional cofactor Fast-1 (FoxH1) [6].
CR-1 and CFC1 proteins contain NH2-terminal signal sequences,
modiﬁed EGF-like domains that bind to Nodal, cysteine-rich CFC
domains that bind to ALK4/7 and COOH-terminal hydrophobic domains
[1,2]. The COOH-terminal hydrophobic domain of human and mouse
CR-1/Cr-1 has been described as a glycosylphosphatidylinositol (GPI)-
attachment signal [7–9] and the COOH-terminal hydrophobic domain of
hCFC1 has been also shown to serve as a membrane-anchoring signal
[10], even though the GPI-attachment of human CFC1 has not been
experimentally demonstrated. The membrane-anchor domain of CFC1
is considered to be important since a frameshift mutation at the
beginning of the membrane-associating domain in human CFC-1 is
related to human left-right laterality defects [10].
Biosynthesis of GPI-anchored proteins requires an NH2-terminal
leader sequence and a COOH-terminal GPI signal sequence which is
recognized by the GPI transamidase complex and then cleaved during
the addition of the GPI moiety [11–13]. The COOH-terminal signal
sequences for GPI-attachment are usually 17 to 31 amino acids in length
and, in most cases, consist of four regions; 1) an unstructured linker
region, 2) a region of small amino acid residues including the ω-site for
propeptide cleavage andGPI-attachment, 3) a hydrophilic spacer region,
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the GPI-transamidase complex after translation of the protein core with
subsequent addition of GPI and signal peptide cleavage which occurs in
the endoplasmic reticulum (ER) [13,16]. Although previous studies have
suggested that artiﬁcially generated, internally positioned GPI-signals
can be substrates for the GPI-transamidase [17,18], all known
endogenous GPI-anchored proteins contain hydrophilic extensions of
no more than a few amino acids [14,17,19,20]. In this context, hCR-1
exhibits a typical sequence of GPI-signal in its COOH-terminus. In
contrast, the COOH-terminal sequence of hCFC1 is not a typical GPI-
signal sequence since the COOH-terminal sequence of hCFC1 contains
an additional 32 amino acids hydrophilic extension (Fig. 1A).
We have previously shown that the GPI-anchor of hCR-1 is
necessary for optimal biological activity of hCR-1 as a co-receptor to
mediate Nodal signaling [9]. Thus, we hypothesized that hCFC1
protein might also be GPI-anchored even though hCFC1 exhibits an
atypical GPI signal sequence. Here we experimentally demonstrate
that both hCR-1 and hCFC1 proteins are GPI-anchored proteins and
deﬁne the different properties of these two GPI-signals. These results
describe the presence of an endogenous non-canonical GPI-signal
sequence with a hydrophilic extension.Fig. 1. Sequence analysis of COOH-terminal domains of EGF-CFC proteins. (A) Sequences of G
aligned using MacVector software. Conserved amino acids are shown at the bottom. (B–E) H
(E). Hydrophobic scores were determined using the Manavalan algorithm with a window s2. Materials and methods
2.1. Cell culture
HEK293T (293T) cells were obtained from ATCC (Manassas, VA)
and maintained in Dulbecco's modiﬁed Eagle's medium supplemen-
ted with 10% fetal bovine serum at 37 °C, in 5% CO2.
2.2. Expression vectors and transfection
The cDNA encoding the open reading frame of hCR-1 was
previously described [8]. The cDNA encoding the open reading
frame of hCFC1 was cloned from NTERA2/D1 embryonal carcinoma
cells and validated by direct sequencing. The obtained sequence of
hCFC1 completely matched the reported sequence (Accession
number; AF312769). All hCR-1- or hCFC1-related constructs except
for the FLAG-tagged constructs were cloned into the pEF6/V5-His
TOPO TA expression vector (Invitrogen, Carlsbad, CA). A chimeric
construct of hCR-1 with the COOH-terminal domain of hCFC1 (CR-
CFC) was generated by PCR-based method using primers; hCR-1
start-F, ACCATGGACTGCAGGAAGATG; CR-CFC chimera-F,PI signal of EGF-CFC proteins. COOH-terminal sequences of indicated gene products are
ydropathy plot of the human CR-1 (B), human CFC1 (C), mouse Cr-1 (D), and mouse cfc1
ize of 11.
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mera-R, GGAGGCCAGGAAGTCTTTCGGATCACAGCCGGGTAGAAATGC;
hCFC1 stop-R, TTAAAGGCGATGCCCAAG. All V5-His tagged constructs
were generated from PCR products with reverse primers without a
stop codon. FLAG-tagged hCR-1 or hCFC1 constructs were generated
with p3xFLAG-Myc-CMV™-24 expression vector (Sigma-Aldrich, St.
Louis, MO) which contains a preprotrypsin signal sequence followed
by three tandem FLAG sequence at the NH2-terminus. DsRed-
Monomer-Golgi expression vector was purchased from Clontech
(Mountain View, CA). Other expression vectors were previously
described [9]. Transfections were performed using Lipofectamine
2000 (Invitrogen) according to the manufacturer's instructions.
2.3. Western blot analysis
Total protein (30 μg/well) or conditioned medium (40 μl/well) was
resolved on 16% gradient SDS-PAGE gels (Invitrogen) and was
transferred to PVDFmembrane (Millipore, Temecula, CA). After blocking
with 5% milk, hCR-1-related proteins were detected with an anti-hCR-1
mousemonoclonal antibody (mAb) (B3F6, Biogen Idec., Cambridge,MA)
at a 1:5000 dilution or with an anti-V5 mouse mAb (Invitrogen) at a
1:5000 dilution and anti-mouse IgG horseradish peroxidase-conjugated
secondary antibody (1:3000, Amersham Biosciences, Piscataway, NJ).
hCFC1-realted proteins were detected with a sheep anti-hCFC1 poly-
clonal antibody (R and D Systems, Minneapolis, MN) at a concentration
of 0.2 μg/mL and anti-sheep IgG horseradish peroxidase-conjugated
secondary antibody (1:3000, Santa Cruz, Santa Cruz, CA). All images of
Western blot analysis in this work were visualized, processed, and
quantiﬁed with Image Analyzer equipped with LabWorks software
(Ultra Violet and Laboratory Produces, Upland, CA).
2.4. Phosphatidylinositol-phospholipase C (PI-PLC) treatment
Transiently transfected 293T cells were collected with enzyme-free
cell dissociation buffer (PBS containing 4mMEDTA). After washingwithFig. 2. GPI-attachment of hCFC-1 protein. (A) Effect of PI-PLC on release of wild-type hCFC1.
enzyme-free cell dissociation buffer and incubated in PBS with the indicated concentration o
and Western blot analysis was carried out using an anti-human CFC1 polyclonal antibody. (B
with or without PI-PLC treatment. 293T cells transfected with the indicated constructs were c
stained with an anti-human CFC1 polyclonal antibody and Alexa Fluor 488-conjugated secon
high and low expression population. (C) [3H]-ethanolamine Metabolic labeling. 293Tcells we
(100 μCi) for 24 h. The cell lysates were subjected to immunoprecipitation using anti-FLAG
autoradiography. ⁎; non-speciﬁc bands.PBS, cells were incubated in suspension with PBS containing 1 unit/
mL of PI-PLC (Sigma-Aldrich, St. Louis, MO) at 37 °C for 30 min, unless
otherwise speciﬁed. Cells were then centrifuged at 10,000 g to divide
pellets and supernatants, followed by Western blot or FACS analysis.
2.5. FACS analysis
293T cells which had been transiently transfected with CR-1- or
CFC1-related expression vectors were collected with enzyme-free cell
dissociation buffer and washed with ice-cold FACS buffer (PBS with
0.1% bovine serum albumin and 0.09% sodium azide). For staining of
cell-surface hCR-1, 1.0×105 cells were incubated for 30 min with
Phycoerythrin (PE)-conjugated anti-hCR-1 mAb (FAB 2772P, R and D
Systems) at a dilution of 1:50. For staining of cell-surface hCFC1, cells
were incubated for 30 min with 50 μg/mL of the sheep anti-hCFC1
polyclonal antibody (R and D Systems), washed with FACS buffer three
times, and incubated with anti-sheep IgG Alexa Fluor 488 conjugate
(1:50, Invitrogen). Cells were then pelleted, resuspended in 500 μL of
ice-cold FACS buffer, and analyzed using a FACScan instrument (BD
Biosciences, San Jose, CA).
2.6. [3H]-ethanolamine metabolic labeling
293T cells were transiently transfected with expression vectors for
FLAG-tagged proteins. After 24 h, [3H]-ethanolamine (100 μCi/mL,
Amersham) was added to culture medium and the cells were
incubated for another 24 h. Cells were washed and lysed in RIPA
buffer (10 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1% NP-40, 1% sodium
deoxycholate, 0.1% SDS, 10 mM EDTA) with complete protease
inhibitor (Roche, Basel, Switzerland). After centrifugation at
14,000 rpm, the supernatants were incubated with anti-FLAG M2
conjugated agarose (Sigma-Aldrich) at room temperature for 1 h. The
beads were washed with RIPA buffer four times, and immunopreci-
pitated proteins were eluted with SDS-PAGE sample loading buffer
containing 2-mercaptoethanol. After SDS-PAGE, the gel was treated293T cells transiently transfected with the hCFC1 expression vector were collected with
f PI-PLC at 37 °C for 30 min. After centrifugation, cells and supernatants were collected
) FACS analysis of cell-surface expression of hCFC1 in transiently transfected 293T cells
ollected and treated with or without PI-PLC (1 unit/mL). After centrifugation, cells were
dary antibody, and FACS analysis was performed. Arrows indicate the two peaks of the
re transiently transfected with indicated constructs and labeled with [3H]-ethanolamine
M2-conjugated agarose. After dissolving on SDS-PAGE, the samples were analyzed by
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the signal. Autoradiography was performed for 14 days.
2.7. Phase separation
Phase separation by Triton X-114 was performed as previously
described [8]. Cells were lysed in Triton X-114 solution (20 mM Tris,
pH 8.0, 150 mM NaCl, 2% Triton X-114) for 1 h on ice. After removal of
cell debris by centrifugation at 14,000 g, phase separation was carried
out bywarming to 37 °C and subsequent centrifugation at 3000 g, 25 °C.
The upper aqueous phase and the lower detergent phasewere carefully
collected by micropipettes. Before applying for Western blotting,
proteins were precipitated with Chrolform-Methanol (1:4, v/v) pre-
cipitation to remove the detergent.
2.8. Immunocytochemistry
293T cells which had been transiently transfected with each CR-1-
or CFC1-related expression vector and/or the Golgi marker DsRed-
Golgi were seeded in poly-L-lysine (Sigma-Aldrich)-coated 4-well
chambered slides 24 h prior to staining. After washing with PBS, cells
were ﬁxed in 4% paraformaldehyde and permeabilized with 0.2%
Triton X-100. CR-1-related proteins were detected with 5 μg/mL of
anti-hCR-1 mAb (MAB2771, R and D Systems) or anti-V5 mAbFig. 3. Generation of a chimeric construct of hCR-1 with GPI signal sequence of hCFC1. (A)
transmembrane form of hCR-1 (CR1TM). Sequences from hCR-1 are shown in red and from
transiently transfected with indicated constructs and PI-PLC treatment (1 unit/mL) was perfo
anti-CR-1 speciﬁc mAb. (C) FACS analysis of cell-surface expression of CR-1 variants in transie
the indicated constructs were collected and treated with or without PI-PLC (1 unit/mL). Cel
indicate the two peaks of the high and low expression population in CR1WT, CR-CFC and C(Invitrogen) at a 1:200 dilution. For co-staining with anti-hCR-
1 mAb (IgG1) and anti-V5 mAb (IgG2a), samples were ﬁrst stained
with anti-V5 mAb and Alexa Fluor 596-conjugated anti-mouse whole
IgG secondary antibody (1:200, Invitrogen) and then stained with
anti-hCR-1 mAb and Alexa Fluor 488-conjugated anti-mouse IgG1-
speciﬁc secondary antibody (1:200, Invitrogen). hCFC1 protein was
stained with 25 μg/mL of the sheep anti-hCFC1 polyclonal antibody (R
and D Systems) and anti-sheep IgG Alexa Fluor 488 conjugate (1:200,
Invitrogen). For confocal images, a Zeiss LSM 510 NLO Meta confocal
system (Carl Zeiss, Oberkochen, Germany) with an Axiovert 200 M
inverted microscope equipped with a 63×NA 1.4 Plan-Apochromat oil
immersion objective lens was used. Z stacks were collected with Zeiss
AIM software using a multi-track conﬁguration.
2.9. Luciferase assay
Dual luciferase assays were performed as described previously [9].
293T cells which had been plated in 24-well cell culture plates were
transfected with an optimized amount of expression vectors ((n2)7-Luc,
50 ng/well; TK-renilla, 5 ng/well; mouse Fast-1, 25 ng/well; mouse
Nodal, 100 ng/well; ALK4-HA, 10 ng/well; hCR-1/hCFC1 variants/
mutants, 5–100 ng/well). pEF6/V5-His empty vector (EV) was used as
a negative control. After 24 h, dual luciferase assays were carried out
using a Dual Luciferase Reporter Assay Kit (Promega, Madison, WI).Schematic of hCR-1 (CR1WT), hCFC1 (CFC1WT), a chimeric construct (CR-CFC), and a
hCFC1 in blue. (B) Effect of PI-PLC on release of CR1WT and CR-CFC. 293T cells were
rmed. Cells and supernatants were collected and analyzed byWestern blotting with an
ntly transfected 293T cells with or without PI-PLC treatment. 293T cells transfected with
ls were stained with PE-conjugated anti-hCR-1 mAb followed by FACS analysis. Arrows
R1TM, respectively.
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Student's T-test was used to determine the statistical signiﬁcance
of the quantitative results. Results with a P valueb0.05 were
considered statistically signiﬁcant.
3. Results
3.1. GPI-anchorage of hCFC1 protein
A majority of EGF-CFC proteins including human CR-1, mouse Cr-1,
and mouse cfc1, exhibit typical amino acid sequences for a GPI-
attachment signal with possible ω-sites, hydrophilic spacer regions,
and hydrophobic domains at the COOH-terminus (Fig. 1A, B, D, E). All
three proteins (human CR-1, mouse Cr-1, and mouse cfc1) were
predicted to be GPI-anchored proteins by a standard prediction
program for the GPI-anchored proteins (‘big-Π predictor’) [15]. Unlike
other EGF-CFC proteins, hCFC1 contains a 32-amino acid of hydro-
philic extension at the COOH-terminal end (Fig. 1A and C) and was not
predicted to be a GPI-anchored protein from its amino acid sequence.
To ascertain if the membrane attachment of hCFC1 protein [10] is
mediated by GPI-anchoring or by other forms of membrane-
anchorage, we analyzed the sensitivity of wild-type hCFC1 to PI-PLC
which is a bacterial enzyme widely used to identify GPI-anchored
proteins [21] in transiently transfected 293T cells (Fig. 2A). PI-PLC
treatment released the CFC1 protein. Released proteins showed
slower SDS-PAGEmobility as compared to the cell-associated proteins,
likely due to the removal of lipid components which exhibit relatively
high afﬁnity to SDS (Fig. 2B). This mobility shift was generally
observed for other GPI-anchored proteins, including CR-1 [8] or an
artiﬁcial GFP-GPI protein (Supplementary Fig. S1). To conﬁrm the
effect of PI-PLC treatment on cell-surface expression of hCFC1,
we performed FACS analysis with or without prior treatment with
PI-PLC (Fig. 2B).Whenwe analyzed cell-surface expression of hCFC1- orFig. 4. Protein analysis of COOH-terminal variant forms of hCR-1. (A) Schematic of COOH-ter
(CR1ΔC). Sequences from hCR-1 are shown in red and from hCFC1 in blue. (B, C) Western blot
transiently transfected with indicated constructs. Immunoblot was performed with anti-hCR
V5 mAb (lower panel). (D) Triton-X114 phase separation analysis of cell lysates from 293T ce
was carried out as described inMaterials andmethods, and aqueous phase (A) and detergent
hCR-1 mAb (upper panel) and the same blots were then stripped and reblotted with the anti
Effect of PI-PLC on release of CR-CFC and CR-CFC-V5. 293T cells were transiently transfected w
supernatants were collected and analyzed by Western blotting with an anti-CR-1 speciﬁc mhCR-1-related proteins in transiently transfected 293Tcells, two distinct
peaks (arrows) were observed which may represent low and high
expressing populations in these transiently transfected cells. PI-PLC
treatment markedly decreased the cell-surface expression of wild-type
CFC1. To directly conﬁrm the GPI-anchorage of human CFC1, we
generated NH2-terminal Flag-tagged expression vectors of CR-1 (Flag-
CR-1), transmembrane form of CR-1 (Flag-CR1TM), and CFC1 (Flag-
CFC1), and performed the metabolic labeling of GPI-anchorage with
[3H]-ethanolamine (Fig. 2C). [3H]-ethanolamine was incorporated into
Flag-CR-1 and Flag-CFC1 but not into Flag-CR1TM. The different band
pattern between the immunoblotting and [3H]-ethanolamine incor-
poration assays suggests that some of the species were not modiﬁed as
GPI-anchored proteins. These results strongly suggest the GPI-ancho-
rage of hCFC1 protein.
To compare the functional difference of COOH-terminal GPI signals
of hCR-1 and hCFC1 within the same background, we generated a
chimeric construct of hCR-1 and the COOH-terminal domain of hCFC1
(CR-CFC) (Fig. 3A). We compared the sensitivity of wild-type hCR-1
(CR1WT) and CR-CFC to PI-PLC (Fig. 3B). CR1WT and CR-CFC proteins
were released into the supernatants after the PI-PLC treatment. FACS
analysis conﬁrmed that CR1WT and CR-CFC chimeric proteins were
sensitive to PI-PLC treatment, whereas CR1TM, a transmembrane form
of hCR-1 was not (Fig. 3C). These results suggest that both GPI signal
sequences of hCR-1 and hCFC1 are functional in the same background.
3.2. Effect of COOH-terminal addition of a hydrophilic peptide tag on
GPI-anchorage of hCR-1 and hCFC1
Previous reports demonstrated that a GPI-signal can function even
when a hydrophilic sequence is artiﬁcially introduced after the
hydrophobic segment [17,18]. However, we have demonstrated that
addition of an artiﬁcial sequence after the COOH-terminal GPI signal of
hCR-1 interfered with the correct localization and biological activity of
the hCR-1 protein [9]. In order to address if an artiﬁcial extension ofminal V5-His-tagged hCR-1 (CR1-V5), CR-CFC (CR-CFC-V5) and a soluble form of hCR-1
analysis of cell lysates (B) and conditioned medium (C) from 293T cells which had been
-1 mAb (upper panel) and the same blots were then stripped and reblotted with an anti-
lls which had been transfected with indicated constructs. Triton-X114 phase separation
phase (D) were analyzed byWestern blotting. Immunoblotwas performedwith the anti-
-V5 mAb (middle panel). Ponceau S staining of the same blot is shown in the bottom. (D)
ith the indicated constructs and PI-PLC treatment (1 unit/mL) was performed. Cells and
Ab.
Fig. 5. FACS analysis of cell-surface expression of hCR-1 variants in transiently
transfected 293T cells with or without PI-PLC treatment. (A, B) Comparison of the cell-
surface expression of CR1WTand CR1-V5 (A) or CR-CFC and CR-CFC-V5 (B) in transiently
transfected 293Tcells. (C, D) 293Tcells which had been transiently transfectedwith CR1-
V5 (C) or CR-CFC-V5 (D) were collected with enzyme-free cell dissociation buffer and
incubated in PBS with or without 1 unit/mL PI-PLC at 37 °C for 30 min. After
centrifugation, cells were collected and stained with PE-conjugated anti-hCR-1 mAb
followed by FACS analysis. Empty vector (EV) was used for a negative control.
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hCFC1 as well as hCR-1, we introduced a V5-His tag that consists of 55
amino acids of which a majority is hydrophilic amino acids at the
COOH-terminal end of hCR-1 and hCFC1 (Fig. 4A). We analyzed the
effect of this artiﬁcial extension to COOH-terminus using CR-1 and CR-
CFC chimeric proteins in order to compare within the same back-
ground. Western blot analysis of cell lysates using a hCR-1-speciﬁc
mAbwhich recognizes an epitope in the NH2-terminal region of hCR-1
[22] revealed that CR1WT protein was primarily produced in two
major forms (∼26-kD and ∼24-kD forms) and a minor ∼18-kDFig. 6. Protein analysis of Flag-tagged hCFC1 variants. (A–B) Western blot analysis of cell lysat
was performed with anti-FLAG mAb (upper panel) and the same blots were then stripped
labeling. 293T cells were transiently transfected with indicated constructs and labele
immunoprecipitation using anti-Flag M2-conjugated agarose. After dissolving on SDS-PAGEfragment and the CR-CFC chimeric protein was produced in three
major forms (∼28-kD, ∼25-kD and ∼23-kD forms) (Fig. 4B). In a
COOH-terminal V5-His tagged form of hCR-1 (CR1-V5), only onemajor
band (∼30 kD) was observed. In contrast, the COOH-terminal V5-His
tagged form of CR-CFC (CR-CFC-V5) was detected as three major forms
(∼38-kD, ∼25-kD and ∼23-kD forms) of which the smaller two bands
were identical to those of CR-CFC protein (∼25-kD and∼23-kD forms).
Immunoblot analysis of the CR1-V5 protein with anti-V5 antibody
detected only a ∼30-kD band which was identical to the form that
was detected by the anti-hCR-1 mAb, suggesting that the cleavage of
COOH-signal does not occur in CR1-V5 at a detectable level (Fig. 4B).
In contrast, only the ∼38-kD form of CR-CFC-V5 was detected with
an anti-V5 antibody but this antibody did not recognize ∼25-kD or
∼23-kD forms of CR-CFC-V5. These results suggest that the ∼25-kD
and ∼23-kD forms of CR-CFC and CR-CFC-V5 are the products after
cleavage of the COOH-terminal signal and probably have been
processed for GPI-anchor attachment, since the removal of GPI
signal sequence of the precursor proteins and its replacement with
GPI moiety are mediated by a catalytic subunit of the GPI
transamidase (GPI8) and occur simultaneously [13,16]. Western
blotting of the conditioned medium revealed that the unprocessed
form of CR-CFC and CR-CFC-V5 (∼28-kD form of CR-CFC and ∼38-kD
form of CR-CFC-V5, respectively) were more abundant than the
processed forms, whereas lesser amounts of CR1WT and none of
CR1-V5 were detected in the conditioned medium (Fig. 4C). Much
higher amounts of the COOH-terminally truncated form of hCR-1
(CR1ΔC) were secreted into the conditioned medium as previously
described [9]. This suggests that the unprocessed forms of CR-CFC
and CR-CFC-V5 do not possess a GPI-anchor and possibly are
directly shunted through a secretory pathway. We then performed
Triton-X114 phase partitioning in order to characterize the hydro-
phobicity of each species of these CR-1/CFC1 variants (Fig. 4D). As
described previously [8], CR1WT was mainly partitioned into the
detergent phase, suggesting the hydrophobic characteristics of the
CR1WT protein. CR1-V5 was more abundant in the aqueous phase. For
the CR-CFC and CR-CFC-V5 proteins, substantial amounts of unpro-
cessed forms (∼28-kD form of CR-CFC and ∼38-kD form of CR-CFC-V5,
respectively) were detected in the aqueous phase whereas the smaller
forms (∼25-kD and ∼23-kD of both variants) were mainly partitioned
into the detergent phase. In addition, PI-PLC treatment released only
the smaller forms (∼25-kD and ∼23-kD of CR-CFC and CR-CFC-V5)
into the supernatants (Fig. 4E). These data strongly support the pos-
sibility that the ∼25-kD and ∼23-kD forms of CR-CFC and CR-CFC-V5
are processed, GPI-anchored forms.es (A) and conditioned medium (B) from transiently transfected 293T cells. Immunoblot
and reblotted with an anti-V5 mAb (lower panel). (D) [3H]-ethanolamine Metabolic
d with [3H]-ethanolamine (100 μCi) for 24 h. The cell lysates were subjected to
, the samples were analyzed by autoradiography. ⁎; non-speciﬁc bands.
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form of hCR-1 by FACS analysis in transiently transfected 293T cells
(Fig. 5). Cell-surface expression of CR1-V5 was signiﬁcantly reduced
compared with that of CR1WT (Fig. 5A). On the other hand, CR-CFC-V5
showed a comparable level of cell-surface expression with CR-CFC
(Fig. 5B). PI-PLC treatment completely abolished the cell-surface
signal of CR1-V5 (Fig. 5C), suggesting that a small fraction of the CR1-
V5 protein could exist as a GPI-anchored form, even though the level is
extremely low as compared to the CR1WT protein. This observation
is consistent with a previous report that demonstrated an internallyFig. 7. Subcellular localization of hCR-1/hCFC1 variants in the COOH-terminal domain. (A–H)
was performed after permeabilization by Triton X-100. CR-1 proteins were stained with a
transfected in A2–F2 (red). Co-staining of V5-tagged constructs with anti-CR-1mAb (G1–H1, gr
with DAPI (blue) and tricolor merged images are shown in A3–H3. Images were visualized b
Scale bar=10 μm. (I–J) Immunocytochemistry of hCFC1 and CFC1-V5 in transiently transfecte
DsRed-Golgi was co-transfected in I2 (red). Arrowheads indicate Golgi localization of CFC1 opositioned GPI-signal can produce GPI-anchored proteins with
reduced efﬁciency [17]. The cell-surface expression of CR-CFC-V5
was also reduced after PI-PLC treatment (Fig. 5D) similar to that
observed for CR-CFC (Fig. 2D).
To ascertain if these results observed in CR-CFC chimeric back-
ground can be observed in hCFC1 background, we utilized Flag-tagged
expression vectors for CR-1, CFC1, and CFC1-V5. Western blot analysis
of cell lysates detected similar band patterns with Flag-tagged forms
of CR-1, CFC1 and CFC1-V5 (Fig. 6A), as compared to the non-tagged
forms of proteins (Fig. 4), respectively. We also detected strong signalsImmunocytochemistry of indicated hCR-1 variants in transiently transfected 293T cells
nti-CR-1 mAb (A1–D1, green) or anti-V5 antibody (E1–F1, green). DsRed-Golgi was co-
een) and anti-V5 antibody (G2–H2, red) is shown in G and H. Nuclei were counterstained
y confocal microscopy. Arrowheads indicate Golgi localization of CR-1 variant protein.
d 293T cells was performed using anti-human CFC1 speciﬁc antibody and anti-V5 mAb.
r CFC1-V5 proteins.
Fig. 8. Co-receptor activities of hCR-1 and hCFC1 variants to mediate Nodal-signaling
pathway. Serum starved 293T cells were transiently transfected with the (n2)7-Luc
reporter, TK renilla reporter, mFast-1, mNodal-V5, ALK4-HA expression vector and the
indicated expression vectors and dual luciferase assay was performed. Values indicate
fold induction of relative luciferase unit against EV. Mean±SD was shown for three
independent experiments. P values were calculated with Student's T-test.
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the conditioned medium, and faint signals were detected for the
mature forms of Flag-CR-1, Flag-CFC1, and FLAG-CFC1-V5 (Fig. 6B).
We then directly addressed the GPI-anchorage of Flag-CFC1, and Flag-
CFC1-V5 by metabolic labeling with [3H]-ethanolamine (Fig. 6C).
[3H]-ethanolamine was equally incorporated into Flag-CFC1, and Flag-
CFC1-V5, and showed identical band patterns, suggesting that the
mature forms of CFC1 protein produced from both constructs were
identical.
We then assessed the intracellular localization of the COOH-
terminal variant forms of hCR-1 and hCFC1 by a confocal microscopy.
The CR1WT protein was detected on the plasma membrane as well as
in intracellular Golgi as assessed by co-transfection with DsRed-Golgi
and stainingwith an anti-hCR-1mAb (Fig. 7A), as previously described
[9]. The CR-CFC and CR-CFC-V5 proteins showed almost identical
staining patterns to the CR1WT protein (Fig. 7B and D). In contrast, the
CR1-V5 protein showed an aberrant cytoplasmic punctate staining
which was not associated with Golgi in most cases (Fig. 7C). The cell-
surface localization of CR1-V5 was not detectable by immunocyto-
chemical analysis, even though a weak cell-surface signal of CR1-V5
was detected by FACS analysis (Fig. 5A), which is likely due to different
sensitivity between these two assays. When the expressed proteins
were visualized with an anti-V5 antibody, CR1-V5 protein was found
to localize in cytoplasmic regions which were not associated with
Golgi (Fig. 7E) and the CR-CFC-V5 protein showed a trans-Golgi
network pattern without plasma membrane staining (Fig. 7F). The
staining pattern of the CR1-V5 protein with the anti-V5 antibody
completely overlapped with the pattern that was detected by the
anti-hCR-1 mAb which can recognize a NH2-terminal epitope in hCR-
1 (Fig. 7G). In contrast, the membrane localization of CR-CFC-V5 was
detectable only with anti-hCR-1 mAb but not with the anti-V5Fig. 9. Biological signiﬁcance of the COOH-terminal hydrophilic extension of hCFC1 in N
Sequences from hCR-1 are shown in red and from hCFC1 in blue. (B) Expression of each
transfected with indicated expression vectors. Total cell lysates (CL) and conditioned med
with the anti-hCR-1 antibody (upper panel) and the same blots were then stripped and
expression for each CR-CFC variant. 293T cells transiently transfected with the indicated ex
FACS. EV was used as a negative control. (D–F) Immunocytochemical analysis of each CR-
were stained with anti-CR-1 mAb (D1–E1) (green). DsRed-Golgi was co-transfected with eac
(F1, green) and anti-V5 antibody (F2, red) is shown in F. Nuclei were counterstained with D
confocal microscopy. Arrowheads indicate Golgi localization of the CR-CFC protein. Scale
transfected with the (n2)7-Luc reporter, TK renilla reporter, mFast-1, mNodal-V5, ALK4-HA
of relative luciferase unit against EV. Mean±SD was shown for three independent experimantibody (Fig. 7H). These results suggest that only the COOH-
terminally processed form(s) of CR-CFC-V5 can be expressed on the
cell surface, conﬁrming that only the products after cleavage of the
COOH-terminal signal are processed for GPI-attachment and
expressed on plasma membrane (Fig. 4). The CFC1WT protein showed
a plasma membrane and Golgi localization pattern that was similar to
the CR1WT protein (Fig. 7I). CFC1-V5 protein was stained differently
with the anti-CFC1 antibody and the anti-V5 antibody (Fig. 7J). V5-tag
was only detected in intracellular Golgi-like structure (Fig. 7J), as
observed in CR-CFC-V5 protein (Fig. 7F and H).
To determine the biological activity of the COOH-terminal variants
of hCR-1 and hCFC1 as Nodal co-receptors, we analyzed the activity of
the expressed proteins in 293T cells using the Activin/Nodal-
responsive (n2)7-luciferase reporter [(n2)7-Luc] (Fig. 8), which
contains mouse Fast-1 binding sites from the Nodal left side-speciﬁc
enhancer [23]. Reporter assays were performed as previously
described [9]. The CR1-V5 protein lost signiﬁcant activity to induce
Nodal signaling as compared to the CR1WT protein, whereas the
activity of V5-tagged hCFC1 (CFC1-V5) and CR-CFC-V5 were compar-
able to that of CFC1WT and CR-CFC, respectively. Importantly, wild-
type hCFC1 (CFC1WT) showed a 50% reduction in activity as compared
to wild-type hCR1 (CR1WT) with respect to mediating Nodal induced
reporter activation in accordance with the precious report [24]. These
results suggest that the addition of an artiﬁcial sequence at the COOH-
terminus did not affect the processing or functional activity for the
GPI-signal of hCFC1, but did reduce the efﬁciency of processing and
activity for that of the hCR-1 protein.
3.3. Functional role of the COOH-terminal hydrophilic extension of hCFC1
in Nodal signaling
To ascertain if the COOH-terminal hydrophilic extension of hCFC1
might have any functional signiﬁcance, we generated a COOH-
terminally truncated construct of CR-CFC (CR-CFC L191stop) in
which the 32 amino acids of COOH-terminal hydrophilic extension
were deleted (Fig. 9A). We also generated the V5-His tagged form of
CR-CFC L191stop (CR-CFC L191-V5) (Fig. 9A). Western blot analysis of
these COOH-terminally truncated forms of CR-CFC revealed that the
CR-CFC L191stop variant produced two major bands of ∼25-kD and
∼23-kD of GPI-processed forms and the CR-CFC L191-V5 variant
protein was processed to ∼25-kD and ∼23-kD GPI-processed forms
and an unprocessed ∼30-kD formwhich was also detected by anti-V5
antibody (Fig. 9B, CL). The GPI-processed forms (∼25-kD and ∼23-kD
forms) are similar to these observed in CR-CFC or CR-CFC-V5 proteins
(Fig. 9B, CL). In the conditioned medium, the unprocessed ∼30-kD
form of the CR-CFC L191-V5 protein was detected at a similar level as
the unprocessed ∼28-kD form of the CR-CFC protein and the
unprocessed ∼38-kD form of the CR-CFC-V5 protein (Fig. 9B, CM).
Lesser amounts of the CR-CFC L191stop protein as compared to the
unprocessed forms of the CR-CFC, CR-CFC-V5 or CR-CFC L191-V5
protein were found in the conditioned medium (Fig. 9B, CM) which
was similar to that observed for the CR1WT protein as compared to
the unprocessed form of the CR-CFC or CR-CFC-V5 protein (Fig. 4C).
FACS analysis revealed that the cell-surface expression of both CR-CFCodal signaling. (A) Schematic of COOH-terminally deleted CR-CFC or CFC1 construct.
CR-CFC variant in cell lysates and conditioned medium. 293T cells were transiently
ium (CM) were collected 24 h after transfection. Immunoblot analysis was performed
reblotted with the anti-V5 antibody (lower panel). (C) FACS analysis of cell-surface
pression vectors were stained with PE-conjugated anti-hCR-1 mAb and analyzed with
CFC variant in transiently transfected 293T cells after permeabilization. CR-1 proteins
h CR-CFC construct in D2–E2 (red). Co-staining of CR-CFC L191-V5 with anti-CR-1 mAb
API (blue) and tricolor merged images are shown in D3–F3. Images were visualized by
bar=10 μm. (G) (n2)7-Luc reporter assay. Serum starved 293T cells were transiently
expression vector and the indicated expression vectors. Values indicate fold induction
ents. P values were calculated with Student's T-test.
2679K. Watanabe et al. / Biochimica et Biophysica Acta 1778 (2008) 2671–2681
2680 K. Watanabe et al. / Biochimica et Biophysica Acta 1778 (2008) 2671–2681L191stop and CR-CFC L191-V5 proteins were similar to that of the
CR-CFC protein (Fig. 9C). A similar membrane and Golgi localization
to the CR-CFC protein was observed with the CR-CFC L191stop and
CR-CFC L191-V5 proteins as detected by immunoﬂuorescent analysis
(Fig. 9D and E). In CR-CFC L191-V5, only perinuclear trans-Golgi but
not plasma membrane detection was observed using the anti-V5
antibody (Fig. 9F), conﬁrming that the V5-tag containing ∼30-kD form
of CR-CFC L191-V5 (Fig. 9B) has not been processed to a GPI-anchored
membrane protein. We then assessed the biological activity of these
COOH-terminally truncated forms of CR-CFC to mediate Nodal-
dependent signaling with the (n2)7-Luc reporter assay (Fig. 9G). The
CR-CFC L191-V5 variant showed similar activity to induce Nodal
signaling as the CR-CFC construct, whereas the CR-CFC L191stop
variant exhibited signiﬁcantly higher activity than the CR-CFC
construct. The co-receptor activity of the CR-CFC L191stop variant
was comparable with that of the CR1WT protein. A comparable
negative effect of the hydrophilic extension was also observed in the
original CFC1 construct. When the hydrophilic region was removed
the ability of the CFC1 protein to mediate Nodal dependent signaling
or a co-receptor increased (CFC1WT versus CFC1 L191stop, Fig. 9G).
These results suggest that the hydrophilic extension of hCFC1 may
negatively regulate the biological activity of hCFC1 to induce Nodal
signaling possibly by reducing efﬁciency to produce a functional GPI-
anchored protein.
4. Discussion
Previous data from our laboratory suggested that GPI-anchorage of
hCR-1 is necessary for optimal biological activity of the protein as a
Nodal co-receptor to mediate Nodal dependent signaling [9]. In the
present study, we experimentally demonstrated that hCFC1, a
member of EGF-CFC proteins and a close relative to hCR-1, is also a
GPI-anchored protein, even though hCFC1 does not exhibit a typical
GPI-signal sequence in the COOH-terminus. Although previous
studies implicated that a GPI-signal can be recognized even when
the signal is positioned internally [17,18], all endogenous GPI-
anchored proteins reported to date contain a hydrophobic domain
at the COOH-terminal end except for a few amino acid extension
[14,17,19,20]. In this context, GPI-signal of hCFC1 is a noncanonical
endogenous GPI-signal which contains a long 32-amino acid hydro-
philic extension at the COOH-terminus. This suggests that other GPI-
anchored proteins might exist, which do not exhibit a canonical GPI-
signal at the extreme COOH-terminal end of the protein. In fact, when
we tested the whole sequence of hCFC1 by three web-based in silico
prediction programs (‘big-Π predictor’, ‘DGPI’, and ‘GPI-SOM’ [20]),
none of these programs was able to predict hCFC1 as a GPI-anchored
protein. However, when we assessed the sequence of hCFC1 without
the 32-amino acid hydrophilic COOH-terminal extension (a.a. 1-191),
all of these programs predicted hCFC1 as a GPI-anchored protein.
Since most of the current algorithms for prediction of GPI-anchored
proteins rely on the core sequences surrounding the ω-site as well as
the physiochemical property of GPI-signal peptides including average
hydrophobicity of the COOH-terminal segments [15,19,20], these
programs could be modiﬁed to include internally positioned GPI-
signals.
A similar hydrophilic extension is found in the CFC1 orthologue in
chimpanzee (Accession number; XP_001144170). Other CFC1 ortho-
logues registered in the NCBI database to date including mouse, rat,
and chicken do not contain this hydrophilic extension and exhibit
typical GPI-signals with hydrophobic segments at the COOH-terminal
end. This suggests that the hydrophilic extension of primate hCFC1
proteins have diverged in evolution for a yet unknown function.
Substitution of this hydrophilic sequence with non-speciﬁc hydro-
philic sequence such as a V5-His tag (CR-CFC L191-V5) did not affect
the localization and biological activity of the CFC1 protein, suggesting
that the hydrophilic extension does not have to be a speciﬁc sequence,which is consistent with previous observations [17,18]. In contrast, the
COOH-terminal addition of the same V5-His tag sequence to the GPI
signal sequence of hCR-1 markedly altered the localization and
decreased the biological activity of the hCR-1 protein to function as
a Nodal co-receptor. This suggests that some GPI-signal sequences can
tolerate the addition of a hydrophilic extension but that others can
not. In fact, the hydrophobic domain of hCFC1 and mcfc1 contain a
leucine repeat that is longer than that of hCR-1 or mCr-1 (Fig. 1). It is
likely that the length and the degree of hydrophobicity of the
hydrophobic segments of the GPI-signal may determine the efﬁciency
of recognition by the GPI-transamidase and GPI-processing.
The signiﬁcance of the hydrophilic amino acid extension in
modulating the biological activity of human CFC1 in vivo during
development is unclear. However, the present results suggest that this
hydrophilic extension may negatively regulate the activity of hCFC1 as
a Nodal co-receptor, and may possibly contribute to the ﬁne tuning of
the intensity of Nodal signaling to establish the precise body
patterning. Moreover, the COOH-terminally epitope-tagged hCFC1
may enable in situ tracking of the GPI-signal peptide and may serve as
a model system to study the biosynthesis of other GPI-anchored
proteins.
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